I 279 Pill - white round, 8mm
Pill with imprint I 279 is White, Round and has been identified as Diclofenac Potassium 50 mg. It is supplied by Ingenus Pharmaceuticals, LLC.
Diclofenac is used in the treatment of Back Pain; Ankylosing Spondylitis; Frozen Shoulder; Chronic Pain; Aseptic Necrosis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. There is positive evidence of human fetal risk during pregnancy. Diclofenac 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for I 279
Diclofenac Potassium
- Imprint
- I 279
- Strength
- 50 mg
- Color
- White
- Size
- 8.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Nonsteroidal anti-inflammatory drugs
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Ingenus Pharmaceuticals, LLC
- National Drug Code (NDC)
- 50742-0279
- Inactive Ingredients
-
lactose anhydrous,
silicon dioxide,
croscarmellose sodium,
triacetin,
hypromelloses,
magnesium stearate,
microcrystalline cellulose,
polydextrose,
polyethylene glycol,
sodium lauryl sulfate,
titanium dioxide
Note: Inactive ingredients may vary.
Related images for "I 279"
More about diclofenac
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (692)
- Drug images
- Latest FDA alerts (11)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Nonsteroidal anti-inflammatory drugs
- Breastfeeding
- En español
Patient resources
- Diclofenac drug information
- Diclofenac (Intravenous) (Advanced Reading)
- Diclofenac (Oral) (Advanced Reading)
- Diclofenac Delayed-Release Tablets
- Diclofenac Capsules
Other brands
Voltaren, Cataflam, Cambia, Voltaren-XR, ... +4 more
Professional resources
- Diclofenac monograph
- Diclofenac (FDA)
- Diclofenac Capsule (FDA)
- Diclofenac Delayed Release Tablets (FDA)
- Diclofenac Extended Release Tablets 100mg (FDA)
Other brands
Voltaren, Cataflam, Cambia, Voltaren-XR, ... +3 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
